The review highlights the prognostic significance of various genetic lesions, such as IKZF1 deletions in BCR-ABL+ ALL and CRLF2 rearrangements in B-ALL, which are associated with poor outcomes. This evidence concerns the gene CRLF2 and acute lymphoblastic leukemia.